Literature DB >> 26603296

Oncogenic Myc Induces Expression of Glutamine Synthetase through Promoter Demethylation.

Alex J Bott1, I-Chen Peng2, Yongjun Fan1, Brandon Faubert3, Lu Zhao4, Jinyu Li5, Sarah Neidler6, Yu Sun1, Nadia Jaber1, Dawid Krokowski7, Wenyun Lu8, Ji-An Pan1, Scott Powers5, Joshua Rabinowitz8, Maria Hatzoglou7, Daniel J Murphy6, Russell Jones3, Song Wu4, Geoffrey Girnun5, Wei-Xing Zong9.   

Abstract

c-Myc is known to promote glutamine usage by upregulating glutaminase (GLS), which converts glutamine to glutamate that is catabolized in the TCA cycle. Here we report that in a number of human and murine cells and cancers, Myc induces elevated expression of glutamate-ammonia ligase (GLUL), also termed glutamine synthetase (GS), which catalyzes the de novo synthesis of glutamine from glutamate and ammonia. This is through upregulation of a Myc transcriptional target thymine DNA glycosylase (TDG), which promotes active demethylation of the GS promoter and its increased expression. Elevated expression of GS promotes cell survival under glutamine limitation, while silencing of GS decreases cell proliferation and xenograft tumor growth. Upon GS overexpression, increased glutamine enhances nucleotide synthesis and amino acid transport. These results demonstrate an unexpected role of Myc in inducing glutamine synthesis and suggest a molecular connection between DNA demethylation and glutamine metabolism in Myc-driven cancers.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26603296      PMCID: PMC4670565          DOI: 10.1016/j.cmet.2015.09.025

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  33 in total

1.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction.

Authors:  David R Wise; Ralph J DeBerardinis; Anthony Mancuso; Nabil Sayed; Xiao-Yong Zhang; Harla K Pfeiffer; Ilana Nissim; Evgueni Daikhin; Marc Yudkoff; Steven B McMahon; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

2.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

Review 3.  Muscle glutamine depletion in the intensive care unit.

Authors:  Gianni Biolo; Francesca Zorat; Raffaella Antonione; Beniamino Ciocchi
Journal:  Int J Biochem Cell Biol       Date:  2005-10       Impact factor: 5.085

4.  Determination of glutamine in muscle protein facilitates accurate assessment of proteolysis and de novo synthesis-derived endogenous glutamine production.

Authors:  K S Kuhn; K Schuhmann; P Stehle; D Darmaun; P Fürst
Journal:  Am J Clin Nutr       Date:  1999-10       Impact factor: 7.045

Review 5.  Localization and function of glutamine synthetase and glutaminase.

Authors:  G Svenneby; I A Torgner
Journal:  Biochem Soc Trans       Date:  1987-04       Impact factor: 5.407

Review 6.  Tumor cell metabolism: cancer's Achilles' heel.

Authors:  Guido Kroemer; Jacques Pouyssegur
Journal:  Cancer Cell       Date:  2008-06       Impact factor: 31.743

7.  Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.

Authors:  Ralph J DeBerardinis; Anthony Mancuso; Evgueni Daikhin; Ilana Nissim; Marc Yudkoff; Suzanne Wehrli; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-21       Impact factor: 11.205

Review 8.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

Authors:  Ralph J DeBerardinis; Julian J Lum; Georgia Hatzivassiliou; Craig B Thompson
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

9.  Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.

Authors:  Sunil R Hingorani; Emanuel F Petricoin; Anirban Maitra; Vinodh Rajapakse; Catrina King; Michael A Jacobetz; Sally Ross; Thomas P Conrads; Timothy D Veenstra; Ben A Hitt; Yoshiya Kawaguchi; Don Johann; Lance A Liotta; Howard C Crawford; Mary E Putt; Tyler Jacks; Christopher V E Wright; Ralph H Hruban; Andrew M Lowy; David A Tuveson
Journal:  Cancer Cell       Date:  2003-12       Impact factor: 31.743

Review 10.  Glutamine and glutamate as vital metabolites.

Authors:  P Newsholme; M M R Lima; J Procopio; T C Pithon-Curi; S Q Doi; R B Bazotte; R Curi
Journal:  Braz J Med Biol Res       Date:  2003-01-29       Impact factor: 2.590

View more
  85 in total

1.  The MYC mRNA 3'-UTR couples RNA polymerase II function to glutamine and ribonucleotide levels.

Authors:  Francesca R Dejure; Nadine Royla; Steffi Herold; Jacqueline Kalb; Susanne Walz; Carsten P Ade; Guido Mastrobuoni; Jens T Vanselow; Andreas Schlosser; Elmar Wolf; Stefan Kempa; Martin Eilers
Journal:  EMBO J       Date:  2017-04-13       Impact factor: 11.598

Review 2.  Review of metabolic pathways activated in cancer cells as determined through isotopic labeling and network analysis.

Authors:  Wentao Dong; Mark A Keibler; Gregory Stephanopoulos
Journal:  Metab Eng       Date:  2017-02-10       Impact factor: 9.783

3.  p97/VCP promotes degradation of CRBN substrate glutamine synthetase and neosubstrates.

Authors:  Thang Van Nguyen; Jing Li; Chin-Chun Jean Lu; Jennifer L Mamrosh; Gang Lu; Brian E Cathers; Raymond J Deshaies
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

Review 4.  Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine.

Authors:  Ji Zhang; Natalya N Pavlova; Craig B Thompson
Journal:  EMBO J       Date:  2017-04-18       Impact factor: 11.598

5.  Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth.

Authors:  Lifeng Yang; Abhinav Achreja; Tsz-Lun Yeung; Lingegowda S Mangala; Dahai Jiang; Cecil Han; Joelle Baddour; Juan C Marini; Joseph Ni; Ryuichi Nakahara; Stephen Wahlig; Lisa Chiba; Sun Hye Kim; Joshua Morse; Sunila Pradeep; Archana Sidalaghatta Nagaraja; Monika Haemmerle; Noh Kyunghee; Mathew Derichsweiler; Thomas Plackemeier; Imelda Mercado-Uribe; Gabriel Lopez-Berestein; Tyler Moss; Prahlad T Ram; Jinsong Liu; Xiongbin Lu; Samuel C Mok; Anil K Sood; Deepak Nagrath
Journal:  Cell Metab       Date:  2016-11-08       Impact factor: 27.287

Review 6.  From Krebs to clinic: glutamine metabolism to cancer therapy.

Authors:  Brian J Altman; Zachary E Stine; Chi V Dang
Journal:  Nat Rev Cancer       Date:  2016-07-29       Impact factor: 60.716

Review 7.  Oxidative Stress in Cancer.

Authors:  John D Hayes; Albena T Dinkova-Kostova; Kenneth D Tew
Journal:  Cancer Cell       Date:  2020-07-09       Impact factor: 31.743

8.  MYC-driven inhibition of the glutamate-cysteine ligase promotes glutathione depletion in liver cancer.

Authors:  Brittany Anderton; Roman Camarda; Sanjeev Balakrishnan; Asha Balakrishnan; Rebecca A Kohnz; Lionel Lim; Kimberley J Evason; Olga Momcilovic; Klaus Kruttwig; Qiang Huang; Guowang Xu; Daniel K Nomura; Andrei Goga
Journal:  EMBO Rep       Date:  2017-02-20       Impact factor: 8.807

9.  Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies.

Authors:  Romain Guièze; Vivian M Liu; Daniel Rosebrock; Alexis A Jourdain; María Hernández-Sánchez; Aina Martinez Zurita; Jing Sun; Elisa Ten Hacken; Kaitlyn Baranowski; Philip A Thompson; Jin-Mi Heo; Zachary Cartun; Ozan Aygün; J Bryan Iorgulescu; Wandi Zhang; Giulia Notarangelo; Dimitri Livitz; Shuqiang Li; Matthew S Davids; Anat Biran; Stacey M Fernandes; Jennifer R Brown; Ana Lako; Zoe B Ciantra; Matthew A Lawlor; Derin B Keskin; Namrata D Udeshi; William G Wierda; Kenneth J Livak; Anthony G Letai; Donna Neuberg; J Wade Harper; Steven A Carr; Federica Piccioni; Christopher J Ott; Ignaty Leshchiner; Cory M Johannessen; John Doench; Vamsi K Mootha; Gad Getz; Catherine J Wu
Journal:  Cancer Cell       Date:  2019-09-19       Impact factor: 31.743

10.  The Mammary Tumor Microenvironment.

Authors:  Colleen S Curran; Suzanne M Ponik
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.